BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7824957)

  • 1. Competitive binding of low molecular mass heparin-tyramine fluorescein-5-isothiocyanate and unlabeled glycosaminoglycans to leukocytes.
    Harenberg J; Malsch R; Piazolo L; Heene DL
    Semin Thromb Hemost; 1994; 20(3):236-44. PubMed ID: 7824957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential binding of heparin to granulocytes of various species.
    Harenberg J; Malsch R; Piazolo L; Huhle G; Heene DL
    Am J Vet Res; 1996 Jul; 57(7):1016-20. PubMed ID: 8807013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of fluorescent-labeled low molecular mass heparin to latex microspheres and to rat and human leukocytes.
    Piazolo L; Harenberg J; Malsch R; Heene DL
    Semin Thromb Hemost; 1994; 20(3):227-35. PubMed ID: 7824956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of heparin binding to human leukocytes using a fluorescein-5-isothiocyanate labeled heparin fragment.
    Harenberg J; Malsch R; Piazolo L; Huhle G; Heene DL
    Cytometry; 1996 Jan; 23(1):59-66. PubMed ID: 14650442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivative.
    Harenberg J; Casu B; Guerrini M; Malsch R; Naggi A; Piazolo L; Torri G
    Semin Thromb Hemost; 2002 Aug; 28(4):343-54. PubMed ID: 12244481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of fluorescent-labeled LMM-heparin in biological fluids using protamine-linked microbeads.
    Malsch R; Melui D; Piazolo L; Harenberg J; Heene DL
    Semin Thromb Hemost; 1997; 23(1):23-30. PubMed ID: 9156407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semisynthesis and analysis of lipophilically modified unfractionated and low molecular mass heparins.
    Malsch R; Harenberg J; Guerrini M; Torri G; Casu B; Heene DL
    Semin Thromb Hemost; 1994; 20(2):182-92. PubMed ID: 7997890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a N'-alkylamine anticoagulant active low-molecular-mass heparin for radioactive and fluorescent labeling.
    Malsch R; Guerrini M; Torri G; Löhr G; Casu B; Harenberg J
    Anal Biochem; 1994 Mar; 217(2):255-64. PubMed ID: 8203754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N' alkylamine low molecular mass heparins (LMM-heparin-tyramine and LMM-heparin-tyramine-fitc) exhibit long lasting anticoagulant effects.
    Malsch R; Piazolo L; Harenberg J; Heene DL
    Thromb Res; 1995 Nov; 80(3):235-46. PubMed ID: 8578550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.
    Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A
    J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against heparin and heparinoids.
    Huhle G; Harenberg J; Malsch R; Heene DL
    Semin Thromb Hemost; 1997; 23(1):17-22. PubMed ID: 9156406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of histamine and histamine analogs to lymphocyte subsets analyzed by flow cytometry.
    Muirhead K; Bender P; Hanna N; Poste G
    J Immunol; 1985 Dec; 135(6):4120-8. PubMed ID: 2415600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates.
    Wang L; Abbasi F; Gaigalas AK; Hoffman RA; Flagler D; Marti GE
    Cytometry B Clin Cytom; 2007 Nov; 72(6):442-9. PubMed ID: 17474131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three heparin bovine serum albumin binding methods for production of antiheparin antibodies.
    Huhle G; Harenberg J; Malsch R; Heene DL
    Semin Thromb Hemost; 1994; 20(2):193-204. PubMed ID: 7997891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
    Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
    Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.
    Fernandez-Botran R; Yan J; Justus DE
    Cytokine; 1999 May; 11(5):313-25. PubMed ID: 10328871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction study between synthetic glycoconjugate ligands and endocytic receptors using flow cytometry.
    Yura H; Ishihara M; Kanatani Y; Takase B; Hattori H; Suzuki S; Kawakami M; Matsui T
    J Biochem; 2006 Apr; 139(4):637-43. PubMed ID: 16672263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
    Corrales I; Weersink AJ; Verhoef J; van Kessel KP
    Immunology; 1993 Sep; 80(1):84-9. PubMed ID: 7503949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.